DaVita Inc. (NYSE:DVA) Shares Sold by Chase Investment Counsel Corp

Chase Investment Counsel Corp trimmed its position in DaVita Inc. (NYSE:DVA) by 1.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 32,764 shares of the company’s stock after selling 320 shares during the period. DaVita accounts for 1.6% of Chase Investment Counsel Corp’s investment portfolio, making the stock its 23rd biggest holding. Chase Investment Counsel Corp’s holdings in DaVita were worth $4,899,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in DVA. FMR LLC increased its position in shares of DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares during the period. Glenmede Trust Co. NA increased its position in shares of DaVita by 731.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 123,269 shares of the company’s stock valued at $20,207,000 after acquiring an additional 108,446 shares during the period. JPMorgan Chase & Co. increased its position in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after acquiring an additional 92,014 shares during the period. KBC Group NV increased its position in shares of DaVita by 27.3% in the 3rd quarter. KBC Group NV now owns 313,519 shares of the company’s stock valued at $51,395,000 after acquiring an additional 67,250 shares during the period. Finally, Strategic Financial Concepts LLC acquired a new position in shares of DaVita in the 4th quarter valued at $9,371,000. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Trading Up 0.7 %

DVA stock opened at $147.83 on Friday. The company’s 50-day simple moving average is $160.66 and its 200-day simple moving average is $158.08. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52-week low of $124.70 and a 52-week high of $179.60. The firm has a market cap of $11.83 billion, a P/E ratio of 13.76, a PEG ratio of 1.07 and a beta of 0.93.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have weighed in on DVA shares. Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st. Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, DaVita presently has a consensus rating of “Hold” and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.